News

sinchew10mon
Zuellig Pharma and Institut AllergoSan sign 10-year regional partnership to bring leading probiotic brand OMNi-BiOTiC® to key markets in Asia
New agreement marks major milestone for Zuellig Pharma as it focuses on expanding its consumer healthcare segment, and for Institut AllergoSan as it expands its global presence SINGAPORE – Media ...
Pharmabiz10mon
Zuellig Pharma signs a 10-year commercialisation partnership with Institut AllergoSan to bring leading probiotic brand OMNi-BiOTiC to key markets in Asia
Zuellig Pharma, a leading healthcare solutions company in Asia, announced that it has signed a 10-year commercialisation partnership with Austria-based Institut AllergoSan, a research and development ...